Press release
Cancer Stem Cells Market Growth Accelerated by Advancements in Targeted Therapy | Merck KGaA, Thermo Fisher Scientific, Inc., Bionomics, AbbVie, Inc., Stemline Therapeutics, Inc, LONZA
Cancer Stem Cells Market
Get exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cancer-stem-cells-market?ophp
Cancer Stem Cells Market Growth
Cancer stem cells market size is estimated to reach at a CAGR of 6.7% during the forecast period (2024-2031).
Comprehensive Insight into Cancer Stem Cells Market Landscape and Growth Trends:
Cancer stem cells are a subpopulation of tumor cells with the ability to self-renew and drive metastasis, recurrence, and therapy resistance. They represent a key focus in oncology R&D for developing targeted and personalized therapies. The CSC market is expanding at a CAGR of 12-15%, supported by increasing biotech investments and a rising incidence of difficult-to-treat cancers, particularly in North America.
The CSC market is expanding with the growth of targeted cancer therapies and personalized medicine. Ongoing research into stem cell markers, tumor microenvironments, and drug resistance is fueling development of innovative treatments, particularly in aggressive and treatment-resistant cancers such as glioblastoma and pancreatic cancer.
Major Players Shaping the Competitive Landscape:
Merck KGaA, Thermo Fisher Scientific, Inc., Bionomics, AbbVie, Inc., Stemline Therapeutics, Inc, LONZA, PromoCell GmbH, Miltenyi Biotec, STEMCELL Technologies Inc and BIOTIME, Inc.
Important Mergers, Acquisitions, and Market Shifts:
▶ April 2025 - AbbVie and Xilio Therapeutics entered a collaboration to develop tumor‐activated immunotherapies geared toward targeting cancer stem cells, enhancing their combined oncology portfolios.
▶ April 2025 - BioTime Inc. introduced a novel stem cell expansion system designed to enhance culture efficiency in cancer stem cell research and therapeutic manufacturing.
▶ April 2025 - Genentech (Roche) began a university collaboration to develop AI-based cancer stem cell detection algorithms utilizing single-cell sequencing data.
▶ March 17, 2025 - AstraZeneca announced its acquisition of EsoBiotec for up to $1 billion, marking a major strategic move into in‐vivo CAR‐T cell therapy platforms targeting cancer stem cells
▶ March 2025 - Stemline Therapeutics launched a clinical study for a CD123-targeting antibody-drug conjugate aimed at acute myeloid leukemia patients with high cancer stem cell burdens.
▶ February 2025 - Verastem Oncology partnered with a Japanese biotech firm to co-develop nanoparticle-based Hedgehog pathway inhibitors designed to target pancreatic cancer stem cells.
▶ January 2025 - Celleron Therapeutics completed a Phase I trial for its WNT pathway inhibitor against colorectal cancer stem cells and is set to commence Phase II trials later in the year.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cancer-stem-cells-market?ophp
Methodology and Scope:
This Cancer Stem Cells Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Cancer Stem Cells Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Cancer Stem Cells market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Cancer Stem Cells industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Cancer Stem Cells market?
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=cancer-stem-cells-market?ophp
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Stem Cells Market Growth Accelerated by Advancements in Targeted Therapy | Merck KGaA, Thermo Fisher Scientific, Inc., Bionomics, AbbVie, Inc., Stemline Therapeutics, Inc, LONZA here
News-ID: 4081168 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Biologics Contract Manufacturing Market Accelerates with Growing B …
Outsourced biologics manufacturing including monoclonal antibodies (mAbs), vaccines, and advanced therapies such as cell and gene treatments has become essential to driving biopharma innovation. According to DataM Intelligence, the global biologics contract manufacturing market was valued at USD 26.03 billion in 2024 and is projected to reach USD 83.47 billion by 2033, expanding at a CAGR of 14.0% between 2025 and 2033.
Download exclusive insights with our detailed sample report (Corporate…
United States Healthcare Data Monetization Market Fueled by Growing Demand for R …
Healthcare data monetization involves transforming patient, claims, EHR, genomic and device-generated information into actionable insights and services. Based on DataM Intelligence analysis, the market was valued at approximately USD 0.6 billion in 2024 and is projected to reach USD 1.35 billion by 2031, reflecting a compound annual growth rate (CAGR) of 19.2%.
The accelerating adoption of artificial intelligence, real-world evidence generation, and cloud analytics platforms are key drivers behind this rapid…
Plant-Based Meat Market 2025 | Growth Drivers, Key Players & Investment Opportun …
Market Size and Growth
Global Plant-based Meat Market reached USD 5.6 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 21.7 billion by 2031. The market is expected to exhibit a CAGR of 20.2% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In July 2025, Impossible Foods launched grilled plant-based chicken strips nationwide, expanding its product line to cater to the growing demand…
United States Detox Drinks Market Outlook | Market Drivers, Innovation & Investo …
Market Size and Growth
Global Detox Drinks Market is expected to exhibit a CAGR of 6.52% during the forecast period (2024-2031).
Key Development:
United States:
✅ In August 2025, PepsiCo launched its Prebiotic Cola, a soda with 30 calories, no artificial sweeteners, and three grams of prebiotic fiber. This move reflects the company's response to the growing demand for functional beverages.
✅ In May 2025, PepsiCo acquired prebiotic soda company Poppi for $1.95 billion,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
